News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,988 Results
Type
Article (9902)
Company Profile (43)
Press Release (273043)
Section
Business (80255)
Career Advice (399)
Deals (17552)
Drug Delivery (27)
Drug Development (43197)
Employer Resources (57)
FDA (7018)
Job Trends (6245)
News (147848)
Policy (12486)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (790)
Accelerated approval (1)
Adcomms (4)
Allergies (33)
Alliances (18216)
ALS (26)
Alzheimer's disease (744)
Antibody-drug conjugate (ADC) (38)
Approvals (7076)
Artificial intelligence (66)
Autoimmune disease (8)
Automation (3)
Bankruptcy (150)
Best Places to Work (5541)
BIOSECURE Act (3)
Biosimilars (39)
Biotechnology (45)
Bladder cancer (33)
Brain cancer (15)
Breast cancer (131)
Cancer (979)
Cardiovascular disease (55)
Career advice (350)
Career pathing (12)
CAR-T (59)
Cell therapy (180)
Cervical cancer (9)
Clinical research (35880)
Collaboration (322)
Compensation (144)
Complete response letters (6)
COVID-19 (981)
CRISPR (16)
C-suite (71)
Cystic fibrosis (42)
Data (1120)
Decentralized trials (1)
Denatured (3)
Depression (14)
Diabetes (113)
Diagnostics (2796)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (19)
Drug discovery (47)
Drug pricing (23)
Drug shortages (3)
Duchenne muscular dystrophy (37)
Earnings (40198)
Editorial (3)
Employer branding (10)
Employer resources (49)
Events (37520)
Executive appointments (271)
FDA (7589)
Featured Employer (3)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (250)
Gene editing (42)
Generative AI (3)
Gene therapy (89)
GLP-1 (242)
Government (1045)
Grass and pollen (1)
Guidances (33)
Healthcare (7040)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (37)
Indications (18)
Infectious disease (1032)
Inflammatory bowel disease (72)
Inflation Reduction Act (7)
Influenza (27)
Intellectual property (48)
Interviews (60)
IPO (9559)
IRA (12)
Job creations (1005)
Job search strategy (313)
Kidney cancer (10)
Labor market (8)
Layoffs (78)
Leadership (3)
Legal (2209)
Liver cancer (36)
Lung cancer (160)
Lymphoma (62)
Machine learning (1)
Management (12)
Manufacturing (98)
MASH (39)
Medical device (4998)
Medtech (4999)
Mergers & acquisitions (8366)
Metabolic disorders (263)
Multiple sclerosis (36)
NASH (9)
Neurodegenerative disease (32)
Neuropsychiatric disorders (6)
Neuroscience (950)
NextGen: Class of 2025 (1970)
Non-profit (831)
Northern California (1256)
Now hiring (4)
Obesity (105)
Opinion (59)
Ovarian cancer (37)
Pain (39)
Pancreatic cancer (52)
Parkinson's disease (58)
Partnered (6)
Patents (118)
Patient recruitment (48)
Peanut (16)
People (20074)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase I (10870)
Phase II (15858)
Phase III (12325)
Pipeline (576)
Podcasts (5)
Policy (22)
Postmarket research (1047)
Preclinical (4329)
Press Release (4)
Prostate cancer (42)
Psychedelics (8)
Radiopharmaceuticals (91)
Rare diseases (158)
Real estate (1531)
Recruiting (23)
Regulatory (10075)
Reports (17)
Research institute (723)
Resumes & cover letters (46)
Rett syndrome (3)
RSV (10)
Schizophrenia (31)
Series A (35)
Series B (13)
Service/supplier (4)
Sickle cell disease (26)
Southern California (1108)
Special edition (3)
Sponsored (10)
Startups (945)
State (1)
Stomach cancer (2)
Supply chain (19)
The Weekly (2)
United States (10581)
Vaccines (182)
Venture capitalists (8)
Webinars (5)
Weight loss (51)
Women's health (10)
Worklife (6)
Date
Last 7 days (372)
Last 30 days (1493)
Last 365 days (18941)
2025 (3248)
2024 (19512)
2023 (22150)
2022 (30080)
2021 (31184)
2020 (27137)
2019 (16882)
2018 (12603)
2017 (13715)
2016 (11508)
2015 (14479)
2014 (10159)
2013 (7317)
2012 (8092)
2011 (8716)
2010 (8287)
Location
Africa (215)
Alabama (27)
Arizona (41)
Arkansas (3)
Asia (16966)
Australia (2060)
California (2814)
Canada (1185)
China (218)
Colorado (120)
Connecticut (119)
Delaware (49)
Europe (31647)
Florida (480)
Georgia (86)
Idaho (17)
Illinois (173)
India (7)
Indiana (136)
Japan (85)
Kansas (58)
Kentucky (5)
Louisiana (1)
Maine (37)
Maryland (391)
Massachusetts (1973)
Michigan (77)
Minnesota (134)
Missouri (30)
Montana (7)
Nebraska (9)
Nevada (28)
New Hampshire (31)
New Jersey (908)
New Mexico (6)
New York (905)
North Carolina (421)
North Dakota (1)
Northern California (1256)
Ohio (72)
Oklahoma (2)
Oregon (9)
Pennsylvania (679)
Puerto Rico (5)
Rhode Island (9)
South America (388)
South Carolina (8)
Southern California (1108)
Tennessee (32)
Texas (459)
Utah (90)
Virginia (60)
Washington D.C. (23)
Washington State (324)
West Virginia (1)
Wisconsin (13)
282,988 Results for "factor bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for Therapeutic Gene Editing
Factor Bioscience Inc. today announced that the United States Patent and Trademark Office (USPTO) has terminated three separate ex parte reexaminations of three U.S. patents owned by Factor.
May 28, 2024
·
3 min read
Press Releases
Rimkus Acquires Human Factors Consulting Services, Incorporated, Enhancing Expertise in Human Factors and Medical Device Consulting
March 6, 2025
·
2 min read
Business
Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science
Factor Bioscience Inc. today announced the addition of three members to its translational science team, which will be led by Kyle Garland, Ph.D., who joins Factor as Director of Translational Science.
April 9, 2024
·
1 min read
Genetown
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024.
April 23, 2024
·
3 min read
Business
Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies
Factor Bioscience Inc. announced the award of a U.S. Department of Defense grant to develop next-generation cell therapy candidates using Factor’s patented mRNA, cell-reprogramming, and gene-editing technologies.
January 9, 2024
·
2 min read
Press Releases
Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
October 18, 2024
·
4 min read
Press Releases
Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
October 17, 2024
·
4 min read
Press Releases
Quadratech Diagnostics Launches Factor-X Activator RVV-X Globally
January 20, 2025
·
1 min read
News
Factor Bioscience to Deliver Presentations at the International Society for Stem Cell Research 2024 Meeting
July 9, 2024
·
3 min read
Press Releases
Pulmonary Embolism Market Size to Reach USD 3.6 Billion by 2035, Impelled by Rising Prevalence of Risk Factors
February 7, 2025
·
9 min read
1 of 28,299
Next
